Search for: "Biogen, Inc. v. Amgen Inc."
Results 1 - 20
of 24
Sort by Relevance
|
Sort by Date
26 Sep 2022, 4:49 am
Full Scope Enablement in Amgen Inc. v. [read post]
1 Jul 2022, 10:02 am
The current most-likely big case is Amgen Inc., et al. v. [read post]
17 Mar 2022, 2:32 pm
See Amgen Inc. v. [read post]
29 Apr 2021, 6:39 am
Amgen v. [read post]
6 Oct 2020, 7:55 am
The decision came in Biogen MA Inc. v. [read post]
28 Sep 2020, 8:00 am
by Dennis Crouch Biogen MA, Inc. v. [read post]
18 Dec 2019, 9:59 pm
For example, in Classen Immunotherapies, Inc. v. [read post]
14 Nov 2019, 6:43 am
Guestkat Rose Hughes walked us through the court's reasoning in relation to the Biogen and Kirin-Amgen cases.GuestKat Rose Hughes responded to an anonymous Katfriend tipper and reported on an interesting update in the progress of the CRISPR/Broad Institute appeal (T0844/18). [read post]
1 Nov 2019, 6:02 am
Biogen insufficiency: Enablement over the entire scope of the claimLord Hoffman established in Biogen Inc v Medeva plc [1997] RPC 1, that a specification must enable the invention to be performed across the full scope of the claim. [read post]
7 Feb 2019, 12:08 pm
Amgen, Inc. [read post]
28 Jun 2016, 6:41 am
Amgen (BPCIA patent dance). [read post]
3 Jun 2016, 6:40 am
Jack Henry & Associates, Inc., No. 15-974 (defining an abstract idea) Biogen MA, Inc. v. [read post]
18 May 2016, 8:19 am
Amgen Inc., et al., No. 15-1039 (Does the notice requirement of the BPCIA create an effective six-month exclusivity post-FDA approval?) [read post]
3 May 2016, 1:42 am
Jack Henry & Associates, Inc., No. 15-974 (defining an abstract idea) Biogen MA, Inc. v. [read post]
18 Apr 2016, 9:58 am
Amgen Inc., et al., No. 15-1039 (Does the notice requirement of the BPCIA create an effective six-month exclusivity post-FDA approval?) [read post]
1 Apr 2016, 8:22 am
Amgen Inc., et al., No. 15-1039 (Does the notice requirement of the BPCIA create an effective six-month exclusivity post-FDA approval?) [read post]
17 Mar 2016, 2:45 am
MPHJ Technology Investments, LLC, No. 15-838 (Federal court jurisdiction in anti-troll consumer protection case) Preclusion or Jurisdiction: Biogen MA, Inc. v. [read post]
4 Mar 2016, 12:25 pm
MPHJ Technology Investments, LLC, No. 15-838 (Federal court jurisdiction in anti-troll consumer protection case) Preclusion or Jurisdiction: Biogen MA, Inc. v. [read post]
5 Jul 2011, 1:44 pm
Sighted this morning, breaking the surface just off the Strand, the judgment of Mr Justice Arnold in MedImmune v Novartis [2011] EWHC 1669 (Pat) certainly fits the legend.In characteristic style, the judgment is as comprehensive as one would wish. [read post]
8 Oct 2009, 6:05 am
Teva Pharmaceuticals USA, Inc (Patent Docs) (Patent Baristas) (GenericsWeb) General Biotech legislative agenda: healthcare, energy, patents and capital (IP Watch) India: Applying for patents does pay: Wockhardt wins kudos from the Indian government (SPICY IP) US: CAFC ruling in Board of Trustees of the Leland Stanford Junior University et al v Roche Molecular Systems et al - How to lose a patent? [read post]
